Zobrazeno 1 - 10
of 183
pro vyhledávání: '"Campone, Mario"'
Autor:
Ginzac A; INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, F- 63000, France. angeline.ginzac@clermont.unicancer.fr.; Centre d'Investigation Clinique UMR501, Clermont-Ferrand, F-63000, France. angeline.ginzac@clermont.unicancer.fr.; Département de Recherche Clinique, Délégation Recherche Clinique et Innovation, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France. angeline.ginzac@clermont.unicancer.fr., Molnar I; INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, F- 63000, France.; Centre d'Investigation Clinique UMR501, Clermont-Ferrand, F-63000, France.; Département de Recherche Clinique, Délégation Recherche Clinique et Innovation, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France., Durando X; INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, F- 63000, France.; Centre d'Investigation Clinique UMR501, Clermont-Ferrand, F-63000, France.; Département de Recherche Clinique, Délégation Recherche Clinique et Innovation, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France.; Service d'oncologie médicale, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France., Motte Rouge T; Service d'oncologie médicale, Centre Eugène MARQUIS, Rennes, France., Petit T; Service d'oncologie médicale, Institut de Cancérologie Strasbourg Europe, Strasbourg, France., D'hondt V; Service d'oncologie médicale, Institut du Cancer de Montpellier Val d'Aurelle, Montpellier, France., Campone M; Service d'oncologie médicale, Institut de Cancérologie de l'Ouest, René GAUDUCHEAU, Saint Herblain, France., Bonichon-Lamichhane N; Service d'oncologie médicale et radiothérapie, Clinique Tivoli, Bordeaux, France., Venat Bouvet L; Service d'oncologie médicale, CHU Dupuytren, Limoges, France., Levy C; Service d'oncologie médicale, Centre François BACLESSE, Caen, France., Augereau P; Service d'oncologie médicale, Institut de Cancérologie de l'Ouest, René GAUDUCHEAU, Saint Herblain, France., Pistilli B; Service d'oncologie médicale, Institut Gustave ROUSSY, Villejuif, France., Arsene O; Service d'oncologie médicale, Centre Hospitalier de Blois, Blois, France., Jouannaud C; Service d'oncologie médicale, Institut Jean GODINOT, Reims, France., Nguyen S; Service d'oncologie médicale, Centre Hospitalier de Pau, Pau, France., Cayre A; Service d'anatomopathologie, Centre Jean PERRIN, Clermont-Ferrand, France., Tixier L; Service d'anatomopathologie, Centre Jean PERRIN, Clermont-Ferrand, France., Mahier Ait Oukhatar C; Unicancer, Paris, France., Nabholtz JM; Centre d'oncologie, Université King Saud (Medical City), Riyadh, Arabi Saoudite., Penault-Llorca F; INSERM U1240 Imagerie Moléculaire et Stratégies Théranostiques (IMoST), Université Clermont Auvergne, Clermont-Ferrand, F- 63000, France.; Service d'anatomopathologie, Centre Jean PERRIN, Clermont-Ferrand, France., Mouret-Reynier MA; Service d'oncologie médicale, Centre Jean PERRIN, Clermont-Ferrand, F-63000, France.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Jun; Vol. 205 (2), pp. 267-279. Date of Electronic Publication: 2024 Mar 07.
Autor:
Giacchetti S; AP-HP, Hôpital Saint Louis, Senologie, Paris and Chronotherapy, Cancers, and Transplantation Unit, Faculty of Medicine, Paris-Saclay University, France; Chronotherapy, Cancers and Transplatation Unit, Faculty of Medicine, Paris-Saclay, Villejuif, France. Electronic address: sylvie.giacchetti@aphp.fr., Laas E; Surgery Department, Institut Curie, Universite Paris Cite, Paris, France; RT2Lab, Residual Tumor and Response to Treatment, U932 'Immunity and Cancer', Universite Paris Cité, Paris, France., Bachelot T; Medical Oncology, Centre Leon Berard, Lyon, France., Lemonnier J; R&D Unicancer, Paris, France., André F; Gustave Roussy, Villejuif, France., Cameron D; ICR-CTSU, Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Bliss J; Medical Oncology, Western General Hospital, Edinburgh, United Kingdom., Chabaud S; Department of Clinical Research and Innovation, Centre Leon Berard, Lyon, France., Hardy-Bessard AC; Medical Oncology, CARIO, Plerin, France., Lacroix-Triki M; Gustave Roussy, Villejuif, France., Canon JL; Medical Oncology, Grand Hopital de Charleroi, Charleroi, Belgium., Debled M; Medical Oncology, Institut Bergonie, Bordeaux, France., Campone M; Medical Oncology, Institut Cancerologie de l'Ouest, Saint Herblain, France., Cottu P; Medical Oncology, Institut Curie, Universite Paris Cite, Paris, France., Dalenc F; Medical Oncology, Oncopole Claudius Regaud, IUCT, Toulouse, France., Ballesta A; U900, Institut Curie, Saint Cloud, France., Penault-Llorca F; Centre Jean Perrin, Université Clermont Auvergne, INSERM, U1240 Imagerie Moléculaire et Stratégies Théranostiques, Clermont Ferrand, France., Asselain B; Arcagy-Gineco, Paris, France., Dumas E; RT2Lab, Residual Tumor and Response to Treatment, U932 'Immunity and Cancer', Universite Paris Cité, Paris, France; Department of Mathematics, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland; (t)'Chronotherapy, Cancers, and Transplantation' Unit, Faculty of Medicine, Paris-Saclay University, Villejuif, France., Reyal F; Surgery Department, Institut Curie, Universite Paris Cite, Paris, France; RT2Lab, Residual Tumor and Response to Treatment, U932 'Immunity and Cancer', Universite Paris Cité, Paris, France., Gougis P; RT2Lab, Residual Tumor and Response to Treatment, U932 'Immunity and Cancer', Universite Paris Cité, Paris, France., Lévi F; Chronotherapy, Cancers and Transplatation Unit, Faculty of Medicine, Paris-Saclay, Villejuif, France., Hamy AS; Medical Oncology, Institut Curie, Universite Paris Cite, Paris, France; RT2Lab, Residual Tumor and Response to Treatment, U932 'Immunity and Cancer', Universite Paris Cité, Paris, France.
Publikováno v:
EBioMedicine [EBioMedicine] 2024 Jun; Vol. 104, pp. 105141. Date of Electronic Publication: 2024 May 07.
Did the COVID-19 pandemic delay treatment for localized breast cancer patients? A multicenter study.
Autor:
Zhou K; Department of Human and Social Sciences, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France., Robert M; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint-Herblain, France., Seegers V; Department of Biostatistics, Institut de Cancérologie de l'Ouest, St-Herblain, France., Blanc-Lapierre A; Department of Biostatistics, Institut de Cancérologie de l'Ouest, St-Herblain, France., Savouroux S; Department of Health Promotion and Prevention, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France., Bigot F; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Angers, France., Frenel JS; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint-Herblain, France., Campone M; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint-Herblain, France., Conroy T; Department of Medical Oncology, Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France., Penault-Llorca F; Department of Biopathology and INSERM U1240, Centre Jean Perrin, Clermont-Ferrand, France., Raoul JL; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Saint-Herblain, France., Bellanger MM; Department of Human and Social Sciences, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France.; Department of Health Promotion and Prevention, Institut de Cancérologie de l'Ouest (ICO), Saint-Herblain, France.
Publikováno v:
PloS one [PLoS One] 2024 May 31; Vol. 19 (5), pp. e0304556. Date of Electronic Publication: 2024 May 31 (Print Publication: 2024).
Autor:
Goetz MP; Mayo Clinic, Rochester, Minnesota., Hamilton EP; Sarah Cannon Research Institute, Tennessee Oncology PLCC, Nashville, Tennessee., Campone M; Institut de Cancerologie de l'Ouest, Angers Cedex, France., Hurvitz SA; University of California, Los Angeles, California., Cortes J; Oncology Department, International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain.; Department of Medicine, Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Madrid, Spain., Johnston S; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Llombart-Cussac A; Hospital Arnau Vilanova, Valencia, Spain., Kaufman PA; University of Vermont Medical Center, Burlington, Vermont., Toi M; Kyoto University, Kyoto, Japan., Jerusalem G; CHU Liege and Liege University, Liege, Belgium., Graham H; Eli Lilly and Company, Indianapolis, Indiana., Wang H; Eli Lilly and Company, Indianapolis, Indiana., Jansen VM; Eli Lilly and Company, Indianapolis, Indiana., Litchfield LM; Eli Lilly and Company, Indianapolis, Indiana., Martin M; Instiuto de Investigacion Santaria Gregorio Maranon, Universidad Complutense, CIBERONC, Madrid, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 15; Vol. 30 (10), pp. 2233-2244.
Autor:
Rugo HS; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA. hope.rugo@ucsf.edu.; Department of Medicine (Hematology/Oncology), University of California San Francisco Helen Diller Family Comprehensive Cancer Center, 1825 4th St., 3rd Floor, San Francisco, CA, 94158, USA. hope.rugo@ucsf.edu., Van Poznak CH; University of Michigan Rogel Cancer Center, Ann Arbor, MI, USA., Neven P; University Hospitals Leuven, Louvain, Belgium., Danielewicz I; Szpital Morski Im. PCK, Gdynia, Poland., Lee SC; National University Hospital (S) Pte Ltd, Singapore, Singapore., Campone M; Institut de Cancerologie de l'Ouest, St Herblain, France., Chik JYK; Queen Elizabeth Hospital, Kowloon, Hong Kong., Vega Alonso E; Centro Integral Oncológico Clara Campal, Madrid, Spain., Naume B; Institute of Clinical Medicine, University of Oslo, and Oslo University Hospital, Oslo, Norway., Brain E; Institut Curie - René-Huguenin Hospital, Saint-Cloud, France., Siegel JM; Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, USA., Li R; Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, USA., Uema D; Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, USA., Wagner VJ; Bayer Consumer Care AG, Basel, Switzerland., Coleman RE; Cancer Clinical Trials Centre, University of Sheffield, Weston Park Hospital, Sheffield, UK. r.e.coleman@sheffield.ac.uk.; Department of Oncology and Metabolism, Cancer Clinical Trials Centre, Weston Park Hospital, Broomcross Building, Floor 2, Whitham Road, Sheffield, S10 2SJ, UK. r.e.coleman@sheffield.ac.uk.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Apr; Vol. 204 (2), pp. 249-259. Date of Electronic Publication: 2023 Dec 20.
Autor:
Vanacker H; Centre Léon Bérard, Lyon, France., Treilleux I; Centre Léon Bérard, Lyon, France., Schiffler C; Centre Léon Bérard, Lyon, France., Bieche I; Institut Curie, Paris, France., Campone M; Institut de cancérologie de l'ouest Pays de Loire Nantes-Angers, Saint-Herblain, France., Patsouris A; Institut de cancérologie de l'ouest Pays de Loire Nantes-Angers, Saint-Herblain, France., Arnedos M; Gustave Roussy, Villejuif, France., Cottu PH; Institut Curie, Paris, France., Jacquin JP; Institut de Cancérologie Lucien Neuwirth, Saint-Priest-En-Jarez, France., Dalenc F; ICR, Institut Universitaire du Cancer de Toulouse, Oncopole, Toulouse, France., Pinton A; Institut Curie, Paris, France., Servant N; Institut Curie, Paris, France., Attignon V; Centre Léon Bérard, Lyon, France., Rouleau E; Gustave Roussy, Villejuif, France., Morel A; Institut de cancérologie de l'ouest Pays de Loire Nantes-Angers, Saint-Herblain, France.; Univ Angers, Nantes Université, Inserm, CNRS, CRCI2NA, SFR ICAT, F-49000, Angers, France., Legrand F; UNICANCER R&D, Paris, France., Jimenez M; UNICANCER R&D, Paris, France., Andre F; Gustave Roussy, Villejuif, France., Bachelot T; Centre Léon Bérard, Lyon, France. thomas.bachelot@lyon.unicancer.fr.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Mar; Vol. 130 (4), pp. 613-619. Date of Electronic Publication: 2024 Jan 05.
Autor:
Campone M; Institut de Cancérologie de l'Ouest, René Gauducheau, Boulevard Jacques Monod, 44805, Saint-Herblain, France. mario.campone@ico.unicancer.fr., Bidard FC; Institut Curie, Paris and Saint-Cloud, France.; Versailles Saint Quentin, Saint-Cloud, France.; Paris-Saclay University, Saint-Cloud, France., Neven P; Department of Gynaecological Oncology, Multidisciplinary Breast Center, University Hospitals Louvain, Campus Gasthuisberg, Leuven, Belgium., Wang L; Sanofi, Cambridge, MA, USA., Ling B; Sanofi, Shanghai, China., Dong Y; Sanofi, Beijing, China., Paux G; Sanofi, Cambridge, MA, USA., Herold C; Sanofi, Cambridge, MA, USA.; Takeda, Cambridge, MA, USA., De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2023 Nov 10; Vol. 25 (1), pp. 141. Date of Electronic Publication: 2023 Nov 10.
Autor:
Balazard F; Owkin Inc, New York, USA., Bertaut A; Centre George François Leclerc, Dijon, France., Bordet É; Sanofi Research and Development, Chilly-Mazarin, France., Mulard S; Owkin Inc, New York, USA., Blanc J; Centre George François Leclerc, Dijon, France., Briot N; Centre George François Leclerc, Dijon, France., Paux G; Sanofi Research and Development, Cambridge, MA, USA., Dhaini Merimeche A; Centre Alexis Vautrin, Vandoeuvre Les Nancy, France., Rigal O; Centre Henri Becquerel, Rouen, France., Coutant C; Centre George François Leclerc, Dijon, France., Fournier M; Institut Bergonié, Bordeaux, France., Jouannaud C; Institut Jean Godinot Reims, France., Soulie P; Institut de Cancérologie de L'Ouest-Centre Paul Papin, Angers, France., Lerebours F; Institut Curie-Hôpital René Huguenin, Saint-Cloud, France., Cottu PH; Institut Curie-Site de Paris, Paris, France., Tredan O; Centre Léon Bérard, Lyon, France., Vanlemmens L; Centre Oscar Lambret, Lille, France., Levy C; Centre François Baclesse, Caen, France., Mouret-Reynier MA; Centre Jean-Perrin Clermont-Ferrand, France., Campone M; Institut de Cancérologie de l'Ouest-Centre René Gauducheau, Nantes Saint Herblain, France., Brady KJS; Sanofi Research and Development, Cambridge, MA, USA., Sasane M; Sanofi Research and Development, Cambridge, MA, USA., Rice M; Sanofi Research and Development, Cambridge, MA, USA., Coulouvrat C; Sanofi Research and Development, Chilly-Mazarin, France., Martin AL; Unicancer, Paris, France., Jacquet A; Unicancer, Paris, France., Vaz-Luis I; Department of Medical Oncology, Gustave Roussy, Villejuif, France., Herold C; Sanofi Research and Development, Cambridge, MA, USA., Pistilli B; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Department of Supportive care and pathways (DIOPP) Oncology, Gustave Roussy, Villejuif, France.; INSERM 981, Gustave Roussy, Villejuif, France.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2023 Sep 07; Vol. 115 (9), pp. 1099-1108.
Autor:
Tolaney SM; Dana-Farber Cancer Institute, Boston, MA., Chan A; Curtin University, Perth, Australia., Petrakova K; Masaryk Memorial Cancer Institute, Brno, Czech Republic., Delaloge S; Institut Gustave Roussy, Villejuif, France., Campone M; Institut de Cancérologie de l'Ouest, René Gauducheau, Saint-Herblain, France., Iwata H; Aichi Cancer Center Hospital, Nagoya, Japan., Peddi PF; Providence Saint John's Cancer Institute, Santa Monica, CA., Kaufman PA; University of Vermont Larner College of Medicine, Burlington, VT., De Kermadec E; Sanofi, Cambridge, MA., Liu Q; Sanofi, Cambridge, MA.; Moderna, Inc, Cambridge, MA., Cohen P; Sanofi, Vitry-sur-Seine, France., Paux G; Sanofi, Cambridge, MA., Wang L; Sanofi, Cambridge, MA., Ternès N; Sanofi, Chilly-Mazarin, France., Boitier E; Sanofi, Chilly-Mazarin, France., Im SA; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University, Seoul, Republic of Korea.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Aug 20; Vol. 41 (24), pp. 4014-4024. Date of Electronic Publication: 2023 Jun 22.
Autor:
Rassy E; Department of Cancer Medicine, University of Paris Saclay, Gustave Roussy, Villejuif, France., Filleron T; BiostatisticsDepartment, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France., Viansone A; Department of Cancer Medicine, University of Paris Saclay, Gustave Roussy, Villejuif, France., Lacroix-Triki M; Department of Biopathology, University of Paris Saclay, Roussy, Villejuif, France., Rivera S; Department of Radiation Therapy, University of Paris Saclay, Gustave Roussy, Villejuif, France., Desmoulins I; Department of Medical Oncology, Centre Oscar Lambret, Lille, France., Serin D; Department of Medical Oncology, Institut Sainte-Catherine, Avignon, France., Canon JL; Department of Medical Oncology, Grand Hôpital de Charleroi, Charleroi, Belgium., Campone M; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Site René Gauducheau, Site Hospitalier Nord, Saint-Herblain, France., Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France., Levy C; Department of Medical Oncology, Centre François Baclesse, Caen, France., Cottu P; Department of Medical Oncology, Institut Curie, Paris, France., Petit T; Department of Medical Oncology, Centre Paul Strauss, Strasbourg, France., Eymard JC; Department of Medical Oncology, Institut Godinot, Reims, France., Debled M; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Bachelot T; Department of Medical Oncology, Centre Leon Berard, Lyon, France., Dalenc F; Department of Medical Oncology, Institut Claudius Regaud, Institut Universitaire Cancer Toulouse-Oncopole, Toulouse, France., Roca L; Institut Régional du Cancer de Montpellier, Parc Euromédecine, Montpellier, France., Lemonnier J; R&D UNICANCER, UCBG, Paris, France., Delaloge S; Department of Cancer Medicine, University of Paris Saclay, Gustave Roussy, Villejuif, France., Pistilli B; Department of Cancer Medicine, University of Paris Saclay, Gustave Roussy, Villejuif, France. barbara.pistilli@gustaveroussy.fr.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Jun; Vol. 199 (2), pp. 371-379. Date of Electronic Publication: 2023 Mar 29.